Clinical trials
Phase 3 Insulin Resistance trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 1 |
| 2008 | 2 |
| 2010 | 1 |
| 2011 | 2 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 15 |
| Recruiting | 2 |
| Withdrawn | 2 |
| Terminated | 1 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Population Health Research Institute | 4 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| Boston Children's Hospital | 1 |
| Clinique Ovo | 1 |
| Cynthia Calkin | 1 |
| Exerkine Corporation | 1 |
| IWK Health Centre | 1 |
| McGill University Health Centre/Research Institute of the McGill University Health Centre | 1 |
| McMaster University | 1 |
| Mount Sinai Hospital, Canada | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Insulin Resistance | 21 |
| Diabetes Mellitus, Type 2 | 7 |
| Diabetes Mellitus | 6 |
| Diabetes Mellitus, Type 1 | 2 |
| Heart Failure | 2 |
| Hyperglycemia | 2 |
| Myocardial Infarction | 2 |
| Obesity | 2 |
| Overweight | 2 |
| Bipolar Disorder | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.